TOURMALINE BIO INC (TRML) Stock Analyst Earnings Estimates
NASDAQ:TRML - Nasdaq - US89157D1054 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 129.17% | N/A -12.63% | N/A 538.37% | N/A 173.96% | N/A 95.71% | N/A 78.77% | |||||||
| EBITDA YoY % growth | -18M | -22.23M -23.50% | -46.89M -110.93% | -74.9M -59.74% | -45.376M 39.42% | -89.693M -97.67% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -18.38M | -22.68M -23.39% | -47.51M -109.48% | -76.28M -60.56% | -45.409M 40.47% | -89.732M -97.61% | N/A -20.59% | N/A -28.64% | N/A -37.79% | N/A -7.20% | N/A 13.67% | N/A 62.69% | N/A 243.44% | N/A 258.65% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -5.53 | -17.90 -223.69% | N/A 80.42% | -2.87 18.11% | N/A -26.66% | N/A -18.21% | N/A -19.90% | N/A -0.77% | N/A 43.03% | N/A 105.43% | N/A 3,033.33% | N/A 184.80% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.96 -41.54% | -0.98 -25.41% | -0.80 6.54% | -0.97 -8.49% | -1.45 -50.49% | -1.51 -54.33% | -1.74 -117.01% |
| Revenue Q2Q % growth | 6.8M | -100.00% | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -27.895M -26.96% | -28.618M -17.11% | -22.917M 11.20% | -33.087M -26.14% | -38.395M -37.64% | -40.133M -40.23% | -46.571M -103.22% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.89 -61.82% | -0.93 | 0.04 | 4.36% |
| Q4 2024 Q2Q % growth | -0.86 -6.17% | -0.89 | 0.03 | 2.86% |
| Q3 2024 Q2Q % growth | -0.78 52.44% | -0.83 | 0.05 | 6.42% |
| Q2 2024 Q2Q % growth | -0.68 -344.44% | -0.73 | 0.05 | 6.54% |
| Q1 2024 Q2Q % growth | -0.55 89.81% | -0.68 | 0.13 | 19.32% |
| Q4 2023 Q2Q % growth | -0.81 81.59% | -0.81 | 0.00 | -0.52% |
| Q3 2023 Q2Q % growth | -1.64 64.35% | -0.96 | -0.68 | -71.05% |
| Q2 2023 Q2Q % growth | 96.52% | -0.15 | % | |
| Q1 2023 Q2Q % growth | -5.40 -20.00% | -3.57 | -1.83 | -51.26% |
| Q4 2022 Q2Q % growth | -4.40 -25.71% | -5.00 | 0.60 | 11.96% |
| Q3 2022 Q2Q % growth | -4.60 -1,337.50% | -4.66 | 0.06 | 1.25% |
| Q2 2022 Q2Q % growth | -4.40 -973.17% | -4.74 | 0.34 | 7.23% |
| Q1 2022 Q2Q % growth | -4.50 -246.15% | -3.57 | -0.93 | -26.05% |
| Q4 2021 Q2Q % growth | -3.50 | -3.57 | 0.07 | 1.96% |
| Q3 2021 Q2Q % growth | -0.32 | -0.30 | -0.02 | -5.75% |
| Q2 2021 Q2Q % growth | -0.41 | -0.27 | -0.14 | -54.60% |
| Q1 2021 Q2Q % growth | -1.30 | -0.27 | -1.03 | -380.95% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -1.15% | 0% | -2.46% |
| Revenue | N/A | N/A | 0% | -10% |